Invivyd, Inc.

IVVD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $226.7M $69.3M $200.6M $92.1M $542.2M $115.0M
Accounts Receivable $13.9M $10.9M $0 — — —
Inventory — $25.9M $0 — — —
Total Current Assets $247.5M $100.7M $224.9M $376.9M $616.7M $117.4M
Property, Plant & Equipment $1.4M $1.5M $1.9M $2.3M $83.0K $0
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — —
Total Assets $276.9M $129.5M $229.2M $383.2M $620.1M $117.4M
Liabilities
Accounts Payable $13.7M $10.4M $8.0M $1.5M $5.8M $8.2M
Total Current Liabilities $34.2M $62.0M $50.3M $25.0M $62.1M $13.1M
Long-Term Debt — — — — — —
Total Liabilities $35.3M $62.0M $51.7M $27.2M $62.1M $13.1M
Stockholders' Equity
Retained Earnings $-954.5M $-902.0M $-732.1M $-533.4M $-292.1M $-65.3M
Total Stockholders' Equity $241.5M $67.5M $177.5M $356.0M $558.0M $-65.2M